{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T01:56:45Z","timestamp":1767059805432,"version":"3.48.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Guangzhou Science and Technology Program","award":["2024A03J1074"],"award-info":[{"award-number":["2024A03J1074"]}]},{"name":"the National Science Foundation of China","award":["82472035"],"award-info":[{"award-number":["82472035"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-02064-7","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T06:53:48Z","timestamp":1764140028000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Application value of radiomics features based on PSMA PET\/CT in diagnosis of clinically significant prostate cancer: a comparison between manual and automatic segmentation"],"prefix":"10.1186","volume":"25","author":[{"given":"Yujun","family":"Geng","sequence":"first","affiliation":[]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Jingwen","family":"Li","sequence":"additional","affiliation":[]},{"given":"Xinzhi","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Junzhang","family":"Tian","sequence":"additional","affiliation":[]},{"given":"Xiaofen","family":"Ma","sequence":"additional","affiliation":[]},{"given":"Kebing","family":"Li","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"issue":"1","key":"2064_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2064_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1148\/radiol.2021202771","volume":"299","author":"C Lawhn-Heath","year":"2021","unstructured":"Lawhn-Heath C, et al. Prostate-specific membrane antigen PET in prostate cancer. Radiology. 2021;299(2):248\u201360.","journal-title":"Radiology"},{"issue":"4","key":"2064_CR3","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s00268-005-0544-5","volume":"30","author":"Y Kinoshita","year":"2006","unstructured":"Kinoshita Y, et al. Expression of Prostate-Specific membrane antigen in normal and malignant human tissues. World J Surg. 2006;30(4):628\u201336.","journal-title":"World J Surg"},{"issue":"3","key":"2064_CR4","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1148\/radiol.211836","volume":"304","author":"A Basso Dias","year":"2022","unstructured":"Basso Dias A, et al. Impact of (18)F-DCFPyL PET on staging and treatment of unfavorable intermediate or High-Risk prostate cancer. Radiology. 2022;304(3):600\u20138.","journal-title":"Radiology"},{"key":"2064_CR5","doi-asserted-by":"crossref","unstructured":"Yadav D et al. 18F-Fluciclovine versus PSMA PET imaging in primary tumor detection during initial staging of high-risk prostate cancer: a systematic review and meta-analysis. Radiology: Imaging Cancer. 2022:4(2).","DOI":"10.1148\/rycan.210091"},{"issue":"1","key":"2064_CR6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.2967\/jnumed.123.266164","volume":"65","author":"L Emmett","year":"2024","unstructured":"Emmett L, et al. Reproducibility and accuracy of the PRIMARY score on PSMA PET and of PI-RADS on multiparametric MRI for prostate cancer diagnosis within a Real-World database. J Nucl Med. 2024;65(1):94\u20139.","journal-title":"J Nucl Med"},{"issue":"3","key":"2064_CR7","doi-asserted-by":"publisher","first-page":"e231407","DOI":"10.1148\/radiol.231407","volume":"309","author":"V Murad","year":"2023","unstructured":"Murad V, et al. Association of PSMA PET-derived parameters and outcomes of patients treated for oligorecurrent prostate cancer. Radiology. 2023;309(3):e231407.","journal-title":"Radiology"},{"key":"2064_CR8","doi-asserted-by":"crossref","unstructured":"Murad V et al. Association of PSMA PET-derived parameters and outcomes of patients treated for oligorecurrent prostate cancer. Radiology, 2023. 309(3).","DOI":"10.1148\/radiol.231407"},{"key":"2064_CR9","doi-asserted-by":"crossref","unstructured":"Lv J et al. A single-center, multi-factor, retrospective study to improve the diagnostic accuracy of primary prostate cancer using [(68)Ga]Ga-PSMA-11 total-body PET\/CT imaging. Eur J Nucl Med Mol Imaging, 2023.","DOI":"10.1007\/s00259-023-06464-1"},{"issue":"2","key":"2064_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1148\/radiol.2021204112","volume":"300","author":"D Deniffel","year":"2021","unstructured":"Deniffel D, et al. Avoiding unnecessary biopsy: MRI-based risk models versus a PI-RADS and PSA density strategy for clinically significant prostate cancer. Radiology. 2021;300(2):369\u201379.","journal-title":"Radiology"},{"issue":"1","key":"2064_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/RLU.0000000000004951","volume":"49","author":"S Guo","year":"2024","unstructured":"Guo S, et al. The PRIMARY score: diagnostic performance and added value compared with MRI in detecting clinically significant prostate cancer. Clin Nucl Med. 2024;49(1):37\u201344.","journal-title":"Clin Nucl Med"},{"key":"2064_CR12","doi-asserted-by":"crossref","unstructured":"Brant A, et al. Risk of tumor upstaging with prostate-Specific membrane antigen positron emission tomography in patients with High-Risk prostate cancer. JAMA Netw Open. 2022;5(9).","DOI":"10.1001\/jamanetworkopen.2022.31101"},{"issue":"6","key":"2064_CR13","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s00259-020-05111-3","volume":"48","author":"C Zamboglou","year":"2020","unstructured":"Zamboglou C, et al. Uncovering the invisible\u2014prevalence, characteristics, and radiomics feature\u2013based detection of visually undetectable intraprostatic tumor lesions in 68GaPSMA-11 PET images of patients with primary prostate cancer. Eur J Nucl Med Mol Imaging. 2020;48(6):1987\u201397.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"2064_CR14","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00259-021-05631-6","volume":"49","author":"Z Yi","year":"2021","unstructured":"Yi Z, et al. Machine learning-based prediction of invisible intraprostatic prostate cancer lesions on 68 Ga-PSMA-11 PET\/CT in patients with primary prostate cancer. Eur J Nucl Med Mol Imaging. 2021;49(5):1523\u201334.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"2064_CR15","first-page":"563","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures. They Are Data Radiol. 2016;278(2):563\u201377.","journal-title":"They Are Data Radiol"},{"issue":"12","key":"2064_CR16","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, et al. Radiomics: the Bridge between medical imaging and personalized medicine. Nat Reviews Clin Oncol. 2017;14(12):749\u201362.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"2","key":"2064_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1148\/radiol.211597","volume":"304","author":"CS Moskowitz","year":"2022","unstructured":"Moskowitz CS, et al. Radiomic analysis: study Design, statistical Analysis, and other bias mitigation strategies. Radiology. 2022;304(2):265\u201373.","journal-title":"Radiology"},{"key":"2064_CR18","doi-asserted-by":"crossref","unstructured":"Stefano A. Challenges and limitations in applying radiomics to PET imaging: possible opportunities and avenues for research. Comput Biol Med, 2024. 179.","DOI":"10.1016\/j.compbiomed.2024.108827"},{"issue":"3","key":"2064_CR19","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1007\/s10278-024-01281-w","volume":"38","author":"G Pasini","year":"2024","unstructured":"Pasini G, et al. Robust [18F]-PSMA-1007 radiomics ensemble model for prostate cancer risk stratification. J Imaging Inf Med. 2024;38(3):1388\u2013402.","journal-title":"J Imaging Inf Med"},{"issue":"4","key":"2064_CR20","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1007\/s00330-022-09264-7","volume":"33","author":"H-Q Liu","year":"2022","unstructured":"Liu H-Q, et al. Machine learning on MRI radiomic features: identification of molecular subtype alteration in breast cancer after neoadjuvant therapy. Eur Radiol. 2022;33(4):2965\u201374.","journal-title":"Eur Radiol"},{"issue":"7","key":"2064_CR21","doi-asserted-by":"publisher","first-page":"5087","DOI":"10.1007\/s00330-023-09410-9","volume":"33","author":"A Jimenez-Pastor","year":"2023","unstructured":"Jimenez-Pastor A, et al. Automated prostate multi-regional segmentation in magnetic resonance using fully convolutional neural networks. Eur Radiol. 2023;33(7):5087\u201396.","journal-title":"Eur Radiol"},{"key":"2064_CR22","doi-asserted-by":"crossref","unstructured":"Dai B, et al. CACA guidelines for holistic integrative management of prostate cancer. Holist Integr Oncol. 2024;3(1).","DOI":"10.1007\/s44178-024-00118-4"},{"key":"2064_CR23","doi-asserted-by":"crossref","unstructured":"Pizzuto DA, et al. 18F-Fluoroethylcholine PET\/CT radiomic analysis for newly diagnosed prostate cancer patients: A monocentric study. Int J Mol Sci. 2022;23(16).","DOI":"10.3390\/ijms23169120"},{"issue":"9","key":"2064_CR24","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","volume":"30","author":"A Fedorov","year":"2012","unstructured":"Fedorov A, et al. 3D slicer as an image computing platform for the quantitative imaging network. Magn Reson Imaging. 2012;30(9):1323\u201341.","journal-title":"Magn Reson Imaging"},{"issue":"6","key":"2064_CR25","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1002\/jmri.27565","volume":"54","author":"C Han","year":"2021","unstructured":"Han C, et al. Radiomics models based on apparent diffusion coefficient maps for the prediction of High-Grade prostate cancer at radical prostatectomy: comparison with preoperative biopsy. J Magn Reson Imaging. 2021;54(6):1892\u2013901.","journal-title":"J Magn Reson Imaging"},{"issue":"21","key":"2064_CR26","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM van Griethuysen","year":"2017","unstructured":"van Griethuysen JJM, et al. Computational radiomics system to Decode the radiographic phenotype. Cancer Res. 2017;77(21):e104\u20137.","journal-title":"Cancer Res"},{"issue":"8","key":"2064_CR27","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1007\/s00259-023-06187-3","volume":"50","author":"S Ghezzo","year":"2023","unstructured":"Ghezzo S, et al. Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer. Eur J Nucl Med Mol Imaging. 2023;50(8):2548\u201360.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"2064_CR28","first-page":"1644","volume":"63","author":"L Emmett","year":"2022","unstructured":"Emmett L, et al. The PRIMARY score: using intraprostatic (68)Ga-PSMA PET\/CT patterns to optimize prostate cancer diagnosis. J Nucl Med. 2022;63(11):1644\u201350.","journal-title":"J Nucl Med"},{"issue":"9","key":"2064_CR29","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.2967\/jnumed.119.235333","volume":"61","author":"C Liu","year":"2020","unstructured":"Liu C, et al. (68)Ga-PSMA PET\/CT combined with PET\/Ultrasound-Guided prostate biopsy can diagnose clinically significant prostate cancer in men with previous negative biopsy results. J Nucl Med. 2020;61(9):1314\u20139.","journal-title":"J Nucl Med"},{"issue":"11","key":"2064_CR30","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1097\/RLI.0000000000000180","volume":"50","author":"D Mackin","year":"2015","unstructured":"Mackin D, et al. Measuring computed tomography scanner variability of radiomics features. Invest Radiol. 2015;50(11):757\u201365.","journal-title":"Invest Radiol"},{"key":"2064_CR31","doi-asserted-by":"publisher","first-page":"103061","DOI":"10.1016\/j.media.2023.103061","volume":"92","author":"Y Huang","year":"2024","unstructured":"Huang Y, et al. Segment anything model for medical images? Med Image Anal. 2024;92:103061.","journal-title":"Med Image Anal"},{"issue":"1","key":"2064_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2967\/jnumed.123.266005","volume":"65","author":"F Wang","year":"2024","unstructured":"Wang F, et al. Comparison of multiple segmentation methods for volumetric delineation of primary prostate cancer with prostate-Specific membrane Antigen-Targeted (18)F-DCFPyL PET\/CT. J Nucl Med. 2024;65(1):87\u201393.","journal-title":"J Nucl Med"},{"key":"2064_CR33","doi-asserted-by":"crossref","unstructured":"Jafari E et al. A convolutional neural network-based system for fully automatic segmentation of whole-body [(68)Ga]Ga-PSMA PET images in prostate cancer. Eur J Nucl Med Mol Imaging. 2023.","DOI":"10.1007\/s00259-023-06555-z"},{"issue":"2","key":"2064_CR34","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1148\/radiol.2019181749","volume":"291","author":"EW Johnston","year":"2019","unstructured":"Johnston EW, et al. VERDICT MRI for prostate cancer: intracellular volume fraction versus apparent diffusion coefficient. Radiology. 2019;291(2):391\u20137.","journal-title":"Radiology"},{"issue":"1","key":"2064_CR35","doi-asserted-by":"publisher","first-page":"78","DOI":"10.5152\/dir.2014.14237","volume":"21","author":"RL Hesketh","year":"2015","unstructured":"Hesketh RL, Zhu AX, Oklu R. Radiomics and Circulating tumor cells: personalized care in hepatocellular carcinoma? Diagn Interv Radiol. 2015;21(1):78\u201384.","journal-title":"Diagn Interv Radiol"},{"key":"2064_CR36","doi-asserted-by":"crossref","unstructured":"Song F et al. A novel feature engineering method based on latent representation learning for radiomics: application in NSCLC subtype classification. IEEE J Biomedical Health Inf. 2023: pp. 1\u201311.","DOI":"10.1109\/JBHI.2023.3290006"},{"issue":"10","key":"2064_CR37","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1007\/s11547-022-01541-1","volume":"127","author":"F Yao","year":"2022","unstructured":"Yao F, et al. Machine learning-based radiomics for multiple primary prostate cancer biological characteristics prediction with 18F-PSMA-1007 PET: comparison among different volume segmentation thresholds. Radiol Med. 2022;127(10):1170\u20138.","journal-title":"Radiol Med"},{"issue":"4","key":"2064_CR38","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1007\/s00259-018-4255-1","volume":"46","author":"J Zhang","year":"2019","unstructured":"Zhang J, et al. Diagnostic performance of 68Ga-PSMA PET\/CT in the detection of prostate cancer prior to initial biopsy: comparison with cancer-predicting nomograms. Eur J Nucl Med Mol Imaging. 2019;46(4):908\u201320.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2064_CR39","doi-asserted-by":"crossref","unstructured":"Leung KH et al. Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET. EJNMMI Res, 2022. 12(1).","DOI":"10.1186\/s13550-022-00948-1"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-02064-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-02064-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-02064-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T01:52:41Z","timestamp":1767059561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-025-02064-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2064"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-02064-7","relation":{},"ISSN":["1471-2342"],"issn-type":[{"type":"electronic","value":"1471-2342"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"10 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance to the Declaration of Helsinki and was approved by the Institutional review board of Guangdong Second Provincial General Hospital. The informed consent was waived by the Institutional review board of Tianjin First Center Hospital due to its retrospective nature.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"528"}}